Loading company…
Valinor uses machine learning to help pharmaceutical and biotech companies plan clinical drug development.
Founded in 2024 and based in San Francisco, Valinor develops machine learning tools for pharmaceutical and biotechnology companies. Its virtual patient models combine longitudinal multi-omics and clinical data to predict treatment outcomes before trials. In December 2025, Valinor raised USD 13.00 mn in Seed funding led by CRV, Pelion Venture Partners, and Harpoon Ventures, with participation from Amino Collective.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in